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The flax rust effector AvrM is a secreted protein of unknown fold that is
recognized by the M resistance protein in flax. In order to investigate the
structural basis of the AvrM–M interaction and possible virulence-associated
functions of AvrM, the C-terminal domains of two different AvrM variants
(AvrM-A and avrM) were crystallized. Crystals of native AvrM-Awere obtained
using pentaerythritol ethoxylate (15/4 EO/OH) as a precipitant and diffracted
X-rays to 2.9 A˚ resolution. Selenomethionine-derivative crystals of similar
quality were obtained using PEG 1500 as a precipitant. Both the native and
selenomethionine-labelled AvrM-A crystals had symmetry of space group C2221
with eight molecules in the asymmetric unit. Crystals of avrM had symmetry of
space group P212121 and diffracted X-rays to 2.7 A˚ resolution. Initial AvrM-A
phases were calculated using the single-wavelength anomalous dispersion
(SAD) method and a partial model was built. Phases for avrM were obtained by
molecular replacement using the partial AvrM-A model.
1. Introduction
Many plant pathogens deliver effector molecules into the plant cell,
where they promote virulence, often by interfering with basal immune
signalling. However, plants have evolved specific immune receptors
known as resistance (R) proteins that recognize these effectors
through direct or indirect mechanisms, resulting in effector-triggered
immunity (ETI; Chisholm et al., 2006; Jones & Dangl, 2006; Rafiqi et
al., 2009; Dodds & Rathjen, 2010). ETI is characterized by localized
cell death, termed the hypersensitive response (HR), at the site of
infection that limits the spread of the pathogen. The effectors that are
detected by the R proteins are often referred to as avirulence (Avr)
proteins because their presence enables the plant to engage an
effective defence response, resulting in the plants being immune to
pathogen infection.
The majority of R proteins are structurally conserved and have a
central nucleotide-binding (NB) domain, a C-terminal leucine-rich-
repeat (LRR) domain and either a coiled-coil (CC) domain or a Toll-
interleukin-1 receptor (TIR) domain at the N-terminus (Martin et al.,
2003). The LRR domain appears to be involved in both recognition
of the effector proteins and negative regulation of the HR (Ellis et al.,
1999; Dodds et al., 2001; Rairdan & Moffett, 2006; Padmanabhan et
al., 2009), while the NB and TIR domains are required for activation
of the R proteins and initiation of defence signalling (Frost et al.,
2004; Lukasik & Takken, 2009; Swiderski et al., 2009; Krasileva et al.,
2010; Bernoux et al., 2011; Williams et al., 2011).
Plant pathogen effectors have few common features and most
of them lack characterized homologues, making it difficult to infer
any molecular function from their sequence alone. Many bacterial
effectors are secreted directly into the host cytosol through the type 3
secretion system and have been shown to interfere with basal immune
responses (Hann et al., 2010). Fungal and oomycete effectors are also
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delivered into the host cell (Panstruga & Dodds, 2009; Tyler, 2009;
Rafiqi et al., 2010; Kale et al., 2010), but data on their molecular
function and virulence targets are scarce.
The interaction between flax (Linum usitatissimum) and the fungal
rust pathogen Melampsora lini is a powerful model system for
studying ETI. Several R genes and corresponding flax rust effector
genes have been identified and some of the effectors, including
AvrL567 and AvrM, encode secreted proteins that are recognized
inside the plant cell by R proteins that belong to the TIR–NB–LRR
class (Dodds et al., 2004; Catanzariti et al., 2006; Wang et al., 2007).
The AvrM effector is recognized by the M resistance protein in flax
and a direct interaction between AvrM andM has been demonstrated
(Catanzariti et al., 2010). In the rust CH5 strain six different variants
(AvrM-A, AvrM-B, AvrM-C, AvrM-D, AvrM-E and avrM) have been
identified, but only four of these proteins (AvrM-A, AvrM-B, AvrM-
C and AvrM-D) are recognized by M and induce HR. AvrM protein
sequences are not related to any other sequences available in the
current databases and their virulence functions and cellular targets
are unknown. Recently, it has been shown that the C-terminal region
of AvrM-A forms a structured domain which is required for recog-
nition by M in flax and for direct interaction with M in yeast two-
hybrid experiments. Biophysical characterization revealed that the
full-length protein has a -helical fold and is a stable dimer in solution
(Catanzariti et al., 2010).
In order to understand the structural basis of the AvrM–M inter-
action and to provide insights into possible virulence-associated
functions of AvrM, we have embarked on determination of its three-
dimensional structure. Here, we report the crystallization and X-ray
diffraction analysis of the C-terminal domain of AvrM-A (residues
103–343) and avrM (residues 46–280). The protein avrM encoded by
the ‘virulence allele’ is not recognized by M and shares 94% sequence
identity with AvrM-A in the C-terminal domain.
2. Materials and methods
2.1. Protein production and purification
Gene fragments encoding residues 103–343 of AvrM-A and resi-
dues 46–280 of avrM (here termed simply ‘AvrM-A’ and ‘avrM’,
respectively) were amplified by PCR using the forward primers
50-TACTTCCAATCCAATGCGCAACCAGAATTTGACAGAGG-
ATTCC-30 and 50-TACTTCCAATCCAATGCGGTTGAAGGG-
ATCCCTCAACCAG-30, respectively, and the same reverse primer
50-TTATCCACTTCCAATGTTACATGTCGGAGATTTCAATAT-
CTTGTTC-30. The PCR products were inserted into the pMCSG7
expression vector using ligation-independent cloning (Stols et al.,
2002). The integrity of the resulting constructs was verified by
sequencing. Both proteins were expressed in Escherichia coli BL21
(DE3) cells using autoinduction medium (Studier, 2005) containing
100 mg ml1 ampicillin. The cells were grown at 310 K to mid-
exponential phase (OD600 nm of approximately 0.6–0.8). The
temperature was then reduced to 293 K and the cultures were grown
for approximately 16 h. The cells were harvested by centrifugation at
5000g and stored at 193 K. Selenomethionine-labelled AvrM-A
was produced in E. coli methionine-auxotroph B834 (DE3) cells
(Novagen). The cells were grown at 310 K in M9 minimal medium
supplemented with 0.2 mM selenomethionine (SeMet) until an
OD600nm of 0.6 was reached. The temperature was then reduced to
293 K and protein expression was induced after 1 h by the addition
of isopropyl -d-1-thiogalactoside to a final concentration of 1 mM.
Growth was continued for a further 16 h at 293 K. The cells were
resuspended in 5 ml pre-chilled lysis buffer (50 mM HEPES pH 8.0,
500 mM NaCl) per gram of cells and lysed using a digitial sonifier
(Branson). The cell debris was removed by centrifugation at 15 000g
for 30 min at 277 K and the resulting supernatant was applied onto a
5 ml HisTrap FF column (GE Healthcare). The column was washed
with 20 column volumes of lysis buffer containing 30 mM imidazole
and the protein was eluted using a linear gradient of imidazole from
30 to 250 mM over 20 column volumes. The fractions containing
AvrM-A and avrM were pooled and the N-terminal His6 tag was
removed by overnight treatment with His6-tagged tobacco etch virus
(TEV) protease (100 ml at 8 mg ml1 per 20 ml of sample) at 277 K in
TEV cleavage buffer (50 mM Tris–HCl pH 8.0, 500 mM NaCl, 1 mM
DTT, 0.5 mM EDTA). Prior to cleavage, the protein was buffer-
exchanged by concentrating the pooled sample to 2 ml using Amicon
ultracentrifugal devices (10 000 Da molecular-weight cutoff; Milli-
pore), followed by subsequent dilution to 20 ml in TEV cleavage
buffer. TEV-cleaved AvrM-A and avrM were purified from the TEV
reaction mixture using the same IMAC strategy as described above.
Column-flowthrough fractions containing cleaved protein were
pooled together and concentrated. AvrM-A and avrM were further
purified by gel filtration on a Superdex 200 HiLoad 26/60 column (GE
Healthcare) pre-equilibrated with 10 mM HEPES pH 7.4, 150 mM
NaCl. The same protocol was used for the purification of the SeMet-
labelled AvrM-A, but 1 mM DTT was included in all buffers. The
peak fractions of AvrM-A and avrM were pooled and concentrated
to final concentrations of 20–90 and 28 mg ml1, respectively, in gel-
filtration buffer. The concentrated protein samples were flash-cooled
as 25 ml aliquots in liquid nitrogen and stored at 193 K. The protein
concentration was determined by measuring the absorbance at
280 nm using an extinction coefficient of 13 410M1 cm1 for both
AvrM-A and avrM (Expasy ProtParam tool; http://ca.expasy.org/
cgi-bin/protparam).
2.2. Crystallization and X-ray diffraction analysis
Initial screening of crystallization conditions was performed in
96-well plates (LabTech) at 293 K using the hanging-drop vapour-
diffusion technique. Several commercial screens were employed,
including Index, PEG/Ion and PEGRx (Hampton Research), Pact
Premier and JCSG+ (Qiagen), Synergy and Axygen (Jena Bio-
sciences) and ProPlex (Molecular Dimensions). 200 nl drops con-
sisting of 100 nl protein solution and 100 nl reservoir solution were
prepared on hanging-drop seals (TTP4150-5100 sourced from
Millennium Science, Australia) using a Mosquito robot (TTP Lab-
Tech, UK) and equilibrated against 100 ml reservoir solution. The
drops were monitored and imaged using the Rock Imager system
(Formulatrix, USA).
Hits from the initial crystallization screens were optimized by
varying the protein concentration, the precipitant concentration, the
pH and the size of the drop. For optimization using streak-seeding,
a cat whisker was passed through a drop containing native crystals
and subsequently passed through 4–6 fresh crystallization drops in a
24-well sitting-drop plate (Cryschem, Hampton Research).
For data collection under cryogenic conditions (100 K), native
AvrM-A crystals were flash-cooled by plunging them directly into a
liquid-nitrogen bath, while SeMet-labelled AvrM-A crystals were
transferred into mother-liquor solution containing 20% ethylene
glycol prior to freezing. The avrM crystals were soaked in Paratone-N
(Hampton Research) before flash-cooling in liquid nitrogen.
Native data sets from single crystals of both AvrM-A and avrM
were collected on the Australian Synchrotron MX2 beamline at
wavelengths of 0.978508 and 0.953940 A˚, respectively, using an
ADSC Quantum 315r CCD detector. For AvrM-A 360 images were
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collected, the crystal-to-detector distance was set to 350 mm and the
oscillation range was 0.5. For avrM, the crystal-to-detector distance
was set to 400 mm, the oscillation range was 1.0 and 180 images were
collected. Data for the SeMet derivative of AvrM-A were collected
on the MX1 beamline of the Australian Synchrotron using an ADSC
Quantum 210r CCD detector. A fluorescence scan was taken around
the selenium absorption edge and diffraction data were collected
at the absorption peak (0.979425 A˚). A total of 720 images were
collected with an oscillation range of 0.5 and a crystal-to-detector
distance of 300 mm.
Data were indexed and integrated using either MOSFLM (Leslie,
1992) or XDS (Kabsch, 2010) and scaled with SCALA within the
CCP4 suite (Winn et al., 2011). SAD phasing was carried out using the
AutoSol automated search routine from the PHENIX program suite
(Adams et al., 2010).
3. Results and discussion
The C-terminal domains of AvrM-A and avrM were purified to >95%
homogeneity as judged by SDS–PAGE (Fig. 1b), with yields of 15
and 10 mg protein per litre of culture, respectively. The gel-filtration
profiles of both proteins (Fig. 1a) are consistent with monodisperse
protein with a molecular weight corresponding to a dimer, which
is consistent with previous observations for full-length AvrM-A
(Catanzariti et al., 2010). Initial crystallization screens of purified
AvrM-A were performed using drops of 200 nl volume in 96-well
microplates and different protein concentrations were trialled (20, 45
and 90 mg ml1). AvrM-A crystals were observed after 3–5 d at
20 mg ml1 in formulations No. 5 (0.1M SPG pH 8, 25% PEG 1500),
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Figure 2
Crystals of AvrM-A and avrM. (a) Native crystals of AvrM-A grown using
pentaerythritol ethoxylate (15/4 EO/OH) with dimensions of 300  200  100 mm.
(b) Similar-sized SeMet-derivative crystals of AvrM-A obtained using PEG 1500
as precipitant. (c) Crystals of avrM grown using sodium citrate. The longest edge
corresponds to approximately 400 mm.
Figure 1
Analysis of AvrM-A and avrM by gel filtration and SDS–PAGE. (a) Elution
profiles of AvrM-A (red) and AvrM (blue) on a Superdex 200 26/60 column. (b)
SDS–PAGE gel of the peak fractions from the chromatogram in (a). Lanes 1 and 2
correspond to AvrM-A and avrM, respectively. Approximately 5 mg protein from
the peak fractions was loaded onto the gel.
No. 16 (0.1MMIB pH 6, 25% PEG 1500) and No. 38 (0.1 MMT pH 6,
25% PEG 1500) of Pact Premier and at 90 mg ml1 in formulation
No. 57 [50 mM bis-tris pH 6.5, 50 mM ammonium sulfate, 30% penta-
erythritol ethoxylate (15/4 EO/OH)] of the Index screen. The crystals
from the latter condition (Fig. 2a) attained final dimensions of 300 
200  100 mm after three weeks and a complete data set to 2.9 A˚
resolution was collected at the Australian Synchrotron from a single
crystal grown from this condition. Analysis of the diffraction data
using POINTLESS (Evans, 2006) identified an orthorhombic lattice
and C2221 as the most likely space group based on systematic
absences. The unit-cell parameters for the AvrM-A crystals were
a = 116.8, b = 131.2, c = 280.3 A˚. The crystals have a Matthews
coefficient (Matthews, 1968) of 2.41 A˚3 Da1 and a solvent content of
49% assuming eight protein molecules per asymmetric unit.
As there is no homologue of AvrM of known structure, the phase
problem had to be solved experimentally. We therefore attempted
to obtain crystals of an SeMet-labelled derivative of AvrM-A. Initial
optimization attempts varying the precipitant concentration, protein
concentration, pH and drop size failed to produce both native and
SeMet-derivatized crystals using the PEG 1500-containing condi-
tions. SeMet-derivatized and native crystals could be produced using
pentaerythritol ethoxylate (15/4 EO/OH), but high nucleation yielded
small crystals that did not diffract X-rays beyond 5 A˚ resolution.
Attempts to lower the nucleation rate by using additives (Additive
Screen HT, Hampton Research), different drop ratios and crystal-
lization under oil (Chayen, 1997) failed to produce larger crystals.
However, when the pentaerythritol ethoxylate (15/4 EO/OH) was
replaced by PEG 1500 the rate of nucleation was reduced and the size
of the crystals was greatly improved. SeMet-derivatized crystals
diffracting X-rays to 3.0–3.5 A˚ resolution were obtained in 20–22%
PEG 1500, 50 mM bis-tris pH 5.9–6.2, 50 mM ammonium sulfate
using a protein concentration of 45 mg ml1 (Fig. 2b). Similar SeMet-
derivatized crystals were also obtained by streak-seeding of native
crystals in 0.1M MMT buffer pH 5.6–6.0, 25% PEG 1500.
Phase information was obtained from an Se-SAD data set at 3.5 A˚
resolution collected from a single crystal grown from seeds in 0.1M
MMT buffer pH 5.8, 25% PEG 1500. The crystal had symmetry of the
same space group as the native crystals and a total of 22 selenium sites
were identified in the asymmetric unit. The initial phases calculated
using AutoSol within the PHENIX suite (Adams et al., 2010; Fig. 3a)
had a figure of merit (FOM) of 0.29. The phases were substantially
improved during density modification to give a final FOM of 0.75 and
the resulting electron density (Fig. 3b) was of sufficient quality to
allow tracing of about 75% of the main-chain atoms of all eight copies
in the asymmetric unit. Manual model building and refinement of the
structure is currently in progress.
In parallel to reproducing and optimizing crystals of AvrM-A,
crystallization screens for avrM were also set up using a concentra-
tion of 28 mg ml1. Rod-shaped crystals were observed after 12–24 h
in 0.1M HEPES pH 7.5, 1.6M sodium citrate tribasic dihydrate
(Index formulation No. 20) and in 1.9M sodium malonate pH 6
(Synergy formulation No. 85). Optimized crystals grew within 5 d in
0.1M MES pH 6.5, 1.3M sodium citrate using a protein concentra-
tion of 10 mg ml1 (Fig. 2c). Data sets to 2.7 A˚ resolution were
collected and analysis of the systematic absences suggested P212121 as
the most likely space group. Data-collection statistics are given in
Table 1. Molecular replacement was performed using Phaser (McCoy
et al., 2007) with a partial model of the AvrM-A monomer as the
search model. Phasing statistics are given in Table 2. One solution
consisting of four monomers was found in space group P212121 with a
crystallization communications
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Table 1
Data-collection statistics.
Values in parentheses are for the highest resolution shell.
AvrM-A SeMet AvrM-A avrM
Space group C2221 C2221 P212121
Unit-cell parameters (A˚)
a 116.8 116.4 88.5
b 131.2 133.7 125.7
c 280.3 281.5 128.9
Molecules per asymmetric unit 8 8 4
Resolution range (A˚) 30–3.0
(3.16–3.00)
93.8–3.5
(3.69–3.50)
19.9–2.7
(2.85–2.70)
No. of unique observations 43446 28160 40138
Completeness (%) 99.9 (99.9) 100.0 (100.0) 99.7 (100.0)
Multiplicity 6.0 (6.1) 14.9 (15.0) 7.3 (7.4)
Rmerge† (%) 10.2 (85.7) 19.0 (74.0) 8.5 (76.6)
Average I/(I) 13.1 (2.3) 13.1 (4.4) 15.0 (2.7)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
an individual measurement of the reflection with Miller indices hkl and hIhkli is the mean
intensity of that reflection. Calculated for I > 3(I).
Table 2
Phasing statistics.
AutoSol
No. of sites (found/all) 24/32
HySS† CC‡ 0.33
SKEW§ 0.09
CORRRMS} 0.75
FOM†† 0.29
Estimated map CC 0.28  0.34
After density modification
R factor 0.29
FOM after density modification 0.75
† Hybrid Substructure Search. ‡ Correlation coefficient. § Skew of the electron
density in the map. } The correlation of local r.m.s. density. †† Figure of merit.
Figure 3
(a) Experimental electron-density map of one section of the asymmetric unit after
initial phasing using AutoSol within PHENIX. (b) The same section after density
modification, with the partially traced main chains shown in red and green
(symmetry-related molecule). Both maps were produced in Coot (Emsley &
Cowtan, 2004) and contoured at 1.0.
final translation-function Z score of 16.5 and a log-likelihood gain
of 787. We now expect that the three-dimensional structures of both
AvrM variants can be determined using the data collected.
References
Adams, P. D. et al. (2010). Acta Cryst. D66, 213–221.
Bernoux, M., Ve, T., Williams, S., Warren, C., Hatters, D., Valkov, E., Zhang,
X., Ellis, J. G., Kobe, B. & Dodds, P. N. (2011). Cell Host Microbe, 9, 200–211.
Catanzariti, A. M., Dodds, P. N., Lawrence, G. J., Ayliffe, M. A. & Ellis, J. G.
(2006). Plant Cell, 18, 243–256.
Catanzariti, A. M., Dodds, P. N., Ve, T., Kobe, B., Ellis, J. G. & Staskawicz, B. J.
(2010). Mol. Plant Microbe Interact. 23, 49–57.
Chayen, N. E. (1997). Structure, 5, 1269–1274.
Chisholm, S. T., Coaker, G., Day, B. & Staskawicz, B. J. (2006). Cell, 124,
803–814.
Dodds, P. N., Lawrence, G. J., Catanzariti, A. M., Ayliffe, M. A. & Ellis, J. G.
(2004). Plant Cell, 16, 755–768.
Dodds, P. N., Lawrence, G. J. & Ellis, J. G. (2001). Plant Cell, 13, 163–178.
Dodds, P. N. & Rathjen, J. P. (2010). Nature Rev. Genet. 11, 539–548.
Ellis, J. G., Lawrence, G. J., Luck, J. E. & Dodds, P. N. (1999). Plant Cell, 11,
495–506.
Emsley, P. & Cowtan, K. (2004). Acta Cryst. D60, 2126–2132.
Evans, P. (2006). Acta Cryst. D62, 72–82.
Frost, D., Way, H., Howles, P., Luck, J., Manners, J., Hardham, A., Finnegan, J.
& Ellis, J. (2004). Mol. Plant Microbe Interact. 17, 224–232.
Hann, D. R., Gimenez-Ibanez, S. & Rathjen, J. P. (2010). Curr. Opin. Plant
Biol. 13, 388–393.
Jones, J. D. & Dangl, J. L. (2006). Nature (London), 444, 323–329.
Kabsch, W. (2010). Acta Cryst. D66, 125–132.
Kale, S. D., Gu, B., Capelluto, D. G., Dou, D., Feldman, E., Rumore, A.,
Arredondo, F. D., Hanlon, R., Fudal, I., Rouxel, T., Lawrence, C. B., Shan,
W. & Tyler, B. M. (2010). Cell, 142, 284–295.
Krasileva, K. V., Dahlbeck, D. & Staskawicz, B. J. (2010). Plant Cell, 22, 2444–
2458.
Leslie, A. G.W. (1992). Jnt CCP4/ESF–EACBMNewsl. Protein Crystallogr. 26.
Lukasik, E. & Takken, F. L. (2009). Curr. Opin. Plant Biol. 12, 427–436.
Martin, G. B., Bogdanove, A. J. & Sessa, G. (2003). Annu. Rev. Plant Biol. 54,
23–61.
Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497.
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni,
L. C. & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674.
Padmanabhan, M., Cournoyer, P. & Dinesh-Kumar, S. P. (2009). Cell.
Microbiol. 11, 191–198.
Panstruga, R. & Dodds, P. N. (2009). Science, 324, 748–750.
Rafiqi, M., Bernoux, M., Ellis, J. G. & Dodds, P. N. (2009). Semin. Cell Dev.
Biol. 20, 1017–1024.
Rafiqi, M., Gan, P. H., Ravensdale, M., Lawrence, G. J., Ellis, J. G., Jones, D. A.,
Hardham, A. R. & Dodds, P. N. (2010). Plant Cell, 22, 2017–2032.
Rairdan, G. J. & Moffett, P. (2006). Plant Cell, 18, 2082–2093.
Stols, L., Gu, M., Dieckman, L., Raffen, R., Collart, F. R. & Donnelly, M. I.
(2002). Protein Expr. Purif. 25, 8–15.
Studier, F. W. (2005). Protein Expr. Purif. 41, 207–234.
Swiderski, M. R., Birker, D. & Jones, J. D. (2009).Mol. Plant Microbe Interact.
22, 157–165.
Tyler, B. M. (2009). Cell. Microbiol. 11, 13–20.
Wang, C. I., Guncar, G., Forwood, J. K., Teh, T., Catanzariti, A. M., Lawrence,
G. J., Loughlin, F. E., Mackay, J. P., Schirra, H. J., Anderson, P. A., Ellis, J. G.,
Dodds, P. N. & Kobe, B. (2007). Plant Cell, 19, 2898–2912.
Williams, S. J., Sornaraj, P., deCourcy-Ireland, E., Menz, R. I., Kobe, B., Ellis,
J. G., Dodds, P. N. & Anderson, P. A. (2011).Mol. Plant Microbe Interact. 24,
897–906.
Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
crystallization communications
Acta Cryst. (2011). F67, 1603–1607 Ve et al.  AvrM 1607
